Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the United Kingdom

J Med Virol. 2021 Oct;93(10):6050-6053. doi: 10.1002/jmv.27162. Epub 2021 Jul 6.

Abstract

During the "first wave" of the coronavirus disease 2019 (COVID-19) pandemic in the United Kingdom (March-June 2020), the city of Leicester was particularly hard hit, resulting in reimposed lockdown measures. Although initial polymerase chain reaction testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was attempted within the community, testing was soon abandoned due to an inability to keep up with demand by local laboratories. It is therefore feasible that undiagnosed transmission of COVID-19 in the community by asymptomatic individuals was a real possibility. Therefore, retrospective SARS-CoV-2 immunoglobulin G (IgG) testing of archived sera from out-patients visiting University Hospitals of Leicester NHS Trust service was performed to investigate the transmission of SARS-CoV-2 in the community. A total of 1779 sera samples were tested from samples collected between 16th March and 3rd June 2020, of which 202 (11.35%) were SARS-CoV-2 IgG positive. Positivity was lowest in March (2.54%) at the beginning of the pandemic before peaking in April (17.16%) before a decline in May and June (11.16% and 12.68%, respectively). This retrospective screening offers some insight into the early patterns of SARS-CoV-2 transmission within a sampled community population during the first wave of the COVID-19 pandemic; supporting the argument for more community screening during high incidences of pandemics.

Keywords: SARS coronavirus; antiviral agents; coronavirus; immune globulin; virus classification.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Viral / blood*
  • COVID-19 / diagnosis*
  • COVID-19 / epidemiology*
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Immunoglobulin G / blood*
  • Immunologic Tests
  • Infant
  • Infant, Newborn
  • Male
  • Mass Screening / statistics & numerical data
  • Middle Aged
  • Pandemics
  • Retrospective Studies
  • United Kingdom / epidemiology
  • Young Adult

Substances

  • Antibodies, Viral
  • Immunoglobulin G